Observational Registry for Dezawa MuseCells Outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry collecting long-term outcomes after Dezawa MuseCells treatment. Participants who received the cells in routine care will complete online surveys about symptoms and clinical outcomes for up to 5 years. Data will focus on conditions like osteoarthritis, pain, wound healing, and related domains, without assigning a new treatment or randomization. The study emphasizes safety and patient-reported outcomes in a real-world setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Received Dezawa MuseCells® as Part of Routine Clinical Care
2. Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up.
3. Willingness to Complete Online Survey Assessments
4. Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period.
5. Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions.
6. Ability to Communicate in the Registry's Supported Language
7. Participants must be able to read and respond to registry surveys in the designated study language.
8. Enrollment Within 12 Months of MuseCell® Administration

Exclusion Criteria:

1. Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included.
2. Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf.
3. Inability to Participate in Long-Term Digital Follow-Up
4. Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes
5. History of Malignancy Diagnosed Within the Past 12 Months
6. Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns.
7. Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality
8. Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods.
9. Pregnant or Actively Breastfeeding at Time of Enrollment

Where it's running

• Bioreset Medical
  North Palm Beach, Florida, United States Recruiting
• Regene Labs
  Guadalajara, Mexico Recruiting

Study contacts

• Study coordinator: MuseCell Information
• Email: info@musecellinnovations.com
• Phone: +65 80166929

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Medial knee osteoarthritis: inside vs outside corticosteroid injection

  This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.

  Recruiting at 5 sites University of Chicago · Bolingbrook, Illinois and 4 other locations · NCT07804446

• Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement

  This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.

  Recruiting University of British Columbia · Vancouver, British Columbia · NCT07696650

• Can robotic-assisted knee replacement with functional alignment improve outcomes vs. standard knee replacement?

  This trial tests whether using the VELYS robotic system during total knee replacement helps patients with knee osteoarthritis feel better and move more comfortably compared with conventional non-robotic surgery.

  Recruiting Golden Jubilee National Hospital · Glasgow, Scotland · NCT07551856

• Screening blood biomarkers for osteoarthritis diagnosis

  This project will test whether certain blood biomarkers can help diagnose osteoarthritis in people aged 40–70 who have had joint pain or stiffness for at least three months.

  Recruiting The First Affiliated Hospital of Xinxiang Medical College · Xinxiang, Henan · NCT07544823

• L‑serine supplements with or without strength training for older adults

  This trial tries daily L‑serine supplements, alone or combined with supervised strength training, to see if they improve thinking, brain health, and physical fitness in healthy 65–85‑year‑olds.

  Recruiting University of Vienna · Vienna, State of Vienna · NCT07466290

• Daily collagen peptides for cellular aging in middle-aged adults

  This trial will test whether taking daily collagen peptides for 24 weeks can stabilize or lengthen telomeres and improve cellular aging markers in adults aged 50–70 with overweight and low-to-moderate physical activity.

  Recruiting University of Vienna · Vienna, State of Vienna · NCT07456449

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.